| Homozygosity of MSH2 c.1906G→C germline mutation is associated with childhood colon cancer, astrocytoma and signs of Neurofibromatosis type I |
|
|
|
|
|
|
|
|
|
| The 4154delA mutation carriers in the BRCA1 gene share a common ancestry |
|
|
|
|
|
|
|
|
|
| A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts |
|
|
|
|
|
|
|
|
|
| Concordant colon tumors in monozygotic twins previously treated for prostate cancer |
|
|
|
|
|
|
|
|
|
| Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer |
|
|
|
|
|
|
|
|
|
| Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment |
|
|
|
|
|
|
|
|
|
| Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations |
|
|
|
|
|
|
|
|
|
| High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers |
|
|
|
|
|
|
|
|
|
| Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services |
|
|
|
|
|
|
|
|
|
| SULT1E1 and ID2 genes as candidates for inherited predisposition to breast and ovarian cancer in Jewish women |
|
|
|
|
|
|
|
|
|
| Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination |
|
|
|
|
|
|
|
|
|
| Analysis of BRCA1/BRCA2 genes’ contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women |
|
|
|
|
|
|
✓ |
|
Jewish Ashkenazi |
| Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis |
|
|
|
|
|
|
|
|
|
| Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening |
|
|
|
|
|
|
|
|
|
| Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore |
|
|
|
|
|
|
|
|
|
| Intussusception in the adult: an unsuspected case of Peutz–Jeghers syndrome with review of the literature |
|
|
|
|
|
|
|
|
|
| Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy |
|
|
|
|
|
|
|
|
|
| Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence |
|
|
|
|
|
|
|
|
|
| 8th International Symposium on von Hippel-Lindau Disease |
|
|
|
|
|
|
|
|
|
| The FAP self-concept scale (adult form) |
|
|
|
|
|
|
|
|
|
| The Inaugural Birt-Hogg-Dubé (BHD) Symposium |
|
|
|
|
|
|
|
|
|
| Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry |
|
|
|
|
|
|
|
|
|
| Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines |
|
|
|
|
|
|
|
|
|
| Absence of founder BRCA1 and BRCA2 mutations in coetaneous malignant melanoma patients of Ashkenazi origin |
|
|
|
|
|
|
✓ |
|
Ashkenazi origin |
| Progression to advanced neoplasia is infrequent in post colectomy familial adenomatous polyposis patients under endoscopic surveillance |
|
|
|
|
|
|
|
|
|
| MLPA mutation detection in Argentine HNPCC and FAP families |
|
|
|
|
|
|
|
|
|
| Psychosocial impact of Peutz-Jeghers Syndrome |
|
|
|
|
|
|
|
|
|
| Predicting breast cancer risk: implications of a “weak” family history |
|
|
|
|
|
|
|
|
|
| Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population |
|
|
|
|
|
|
|
|
|
| Identification of a mutation in exon 27 of the RB1 gene associated with incomplete penetrance retinoblastoma |
|
|
|
|
|
|
|
|
|
| The three nucleotide deletion within the 3′untranslated region of MLH1 resulting in gene expression reduction is not a causal alteration in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes |
|
|
|
|
|
|
|
|
|
| Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas |
|
|
|
|
|
|
|
|
|
| Mutation spectrum in HNPCC in the Israeli population |
|
|
|
|
|
|
|
|
|
| Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer |
|
|
|
|
|
|
|
|
|
| Cascade genetic testing for mismatch repair gene mutations |
|
|
|
|
|
|
|
|
|
| Family history and colorectal cancer survival in women |
|
|
|
|
|
|
|
|
|
| Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer |
|
|
|
|
|
|
|
|
|
| Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women |
|
|
|
|
|
|
|
|
|
| Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers |
|
|
|
|
|
|
|
|
|
| Tumor histology helps to identify Lynch syndrome among colorectal cancer patients |
|
|
|
|
|
|
|
|
|
| Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba |
|
|
|
|
|
|
|
|
|
| Prolactin and systemic malignancies: a close association |
|
|
|
|
|
|
|
|
|
| Inequality of use of Cancer Genetics Services by members of breast, ovarian and colorectal cancer families in South East Scotland |
|
|
|
|
|
|
|
|
|
| Muir-Torre Syndrome: expanding the genotype and phenotype—a further family with a MSH6 mutation |
|
|
|
|
|
|
|
|
|
| Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer |
|
|
|
|
|
|
|
|
|
| Family history of cancer in Brazil: is it being used? |
|
|
|
|
|
|
|
|
|
| Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation |
|
|
|
|
|
|
|
|
|